Cargando…
Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII
Anti-drug antibodies to coagulation factor VIII (fVIII), often termed inhibitors, present the greatest economical and treatment related obstacle in the management of hemophilia A. Although several genetic and environmental risk factors associated with inhibitor development have been identified, the...
Autores principales: | Zakas, Philip M., Healey, John F., Smith, Ian W., Lillicrap, David, Lollar, Pete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020254/ https://www.ncbi.nlm.nih.gov/pubmed/32117290 http://dx.doi.org/10.3389/fimmu.2020.00150 |
Ejemplares similares
-
Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
por: Healey, J. F., et al.
Publicado: (2018) -
On computational approaches for size-and-shape distributions from sedimentation velocity analytical ultracentrifugation
por: Schuck, Peter
Publicado: (2009) -
Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner
por: Batsuli, Glaivy, et al.
Publicado: (2023) -
A simple cell-alignment protocol for sedimentation velocity analytical ultracentrifugation to complement mechanical and optical alignment procedures
por: Channell, Guy, et al.
Publicado: (2018) -
Analysis of High Affinity Self-Association by Fluorescence Optical Sedimentation Velocity Analytical Ultracentrifugation of Labeled Proteins: Opportunities and Limitations
por: Zhao, Huaying, et al.
Publicado: (2013)